A National Study of the Retention of Irish Opiate Users in Methadone Substitution Treatment

REFERENCES

• Ireland: New developments, trends and in-depth information on selected issues. National Report to the EMCDDA by the Reitox, National Focal Point. Dublin: Drug Misuse Research Division Health Research Board, 2006.
   Google Scholar
• Report of the Methadone Treatment Services Review Group. Dublin: Department of Health and Children, 2005.
   Google Scholar
• Farrell M, Barry J. The Introduction of the Opioid Treatment Protocol. Dublin: Health Services Executive, 2010.
   Google Scholar
• Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 1998; 93(4):515–532.
   PubMed Web of Science ®Google Scholar
• Farré M, Mas A, Torrens M, Moreno V, Cami´ J. Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis. Drug Alcohol Depend 2002; 65(3): 283–290.
   PubMed Web of Science ®Google Scholar
• Simpson DD. Introduction to 5-year followup treatment outcome studies. J Subst Abuse Treat 2003; 25(3):123–124.
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, Stewart D, Lehmann P, Strang J. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: Results from the National Treatment Outcome Research Study. Br J Gen Pract 1999; 49(438):31–34.
   PubMed Web of Science ®Google Scholar
• Teesson M, Havard A, Ross J, Darke S. Outcomes after detoxification for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2006; 25(03):241–247.
   PubMedGoogle Scholar
• Comiskey C, Kelly P, Leckey Y, McCullough L, ODuill B, Stapleton R, White E. The ROSIE Study: Drug Treatment Outcomes in Ireland. Dublin: National Advisory Committee on Drugs, 2009.
   Google Scholar
• Ward JMR, Hall W. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam: Harwood Academic Publishers, 1998.
   Google Scholar
• Cox G, Comiskey C, Kelly P. Summary of 1-Year Outcomes: Methadone Modality. Dublin: National Advisory Committee on Drugs, 2007.
   Google Scholar
• Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. London, UK: Chapel Hill, 1989.
   Google Scholar
• Simpson DD, Joe GW, Brown BS. Treatment retention and follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav 1997; 11(4):294–307.
   Web of Science ®Google Scholar
• Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999; 353(9148):221–226.
   PubMed Web of Science ®Google Scholar
• Comiskey C, Stapleton R. Treatment pathways and longitudinal outcomes for opiate users: Implications for treatment policy and planning. Drugs Educ Prev Pol 2010; 17(6):707–717.
   Web of Science ®Google Scholar
• Magura S, Nwakeze PC, Demsky S. Research report: Pre-and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998; 93(1):51–60.
   PubMed Web of Science ®Google Scholar
• Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP. Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug Alcohol Depend 2011; 117:170–175.
   PubMed Web of Science ®Google Scholar
• Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006; 82(3):211–217.
   PubMed Web of Science ®Google Scholar
• Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence (review). Cochrane Database Syst Rev 2007; 3( CD002208).
   Google Scholar
• Villafranca SW, McKellar JD, Trafton JA, Humphreys K. Predictors of retention in methadone programs: A signal detection analysis. Drug Alcohol Depend 2006; 83(3):218–224.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brlen CP. The effects of psychosocial services in substance abuse treatment. J Addict Nurs 1993; 5(2):38–47.
   Google Scholar
• Amato L, Davoli MA, Perucci C, Ferri M, Faggiano F,P, Mattick R. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28(4):321–329.
   PubMed Web of Science ®Google Scholar
• Brady TM, Salvucci S, Sverdlov LS, Male A, Kyeyune H, Sikali E, Desale S, Yu P. Methadone dosage and retention: An examination of the 60 mg/day threshold. J Addict Dis 2005; 24(3):23–47.
   PubMed Web of Science ®Google Scholar
• Henry-Edwards S, Gowing L, White J, Ali R, Bell J, Brough R, Lintzeris N, Ritter A, Quigley A. Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence. In Pharmacotherapies for the Treatment of Opiod Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines. Mattick R, Ali R, Lintzeris N, eds. London: Informa Healthcare, 2009; 354–389.
   Google Scholar
• Bacha J, Reast S, Pearlstone A. Treatment practices and perceived challenges for European physicians treating opioid dependence. Heroin Addict Relat Clin Probl 2010; 12(3):9–19.
   Web of Science ®Google Scholar
• Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial. J Am Med Assoc 1999; 281(11):1000–1005.
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 2001; 62(3):255–264.
   PubMed Web of Science ®Google Scholar
• D’Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bargagli AM. Retention in treatment of heroin users in Italy: The role of treatment type and of methadone maintenance dosage. Drug Alcohol Depend 1998; 52(2):167–171.
   PubMed Web of Science ®Google Scholar
• Comiskey CM, Cox G. Analysis of the impact of treatment setting on outcomes from methadone treatment. J Subst Abuse Treat 2010; 39(3):195–201.
   PubMed Web of Science ®Google Scholar
• Glanz A. Findings of a national survey of the role of general practitioners in the treatment of opiate misuse: Views on treatment. Br Med J (Clinical Research Ed.) 1986; 293(6546):543.
   PubMedGoogle Scholar
• Glanz A, Taylor C. Findings of a national survey of the role of general practitioners in the treatment of opiate misuse: Extent of contact with opiate misusers. Br Med J (Clinical Research Ed.) 1986; 293(6544):427.
   PubMedGoogle Scholar
• Fiellin DA, O’Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: A randomized controlled trial. J Am Med Assoc 2001; 286(14):1724–1731.
   PubMed Web of Science ®Google Scholar
• Strang J, Sheridan J, Hunt C, Kerr B, Gerada C, Pringle M. The prescribing of methadone and other opioids to addicts: National survey of GPs in England and Wales. Br J Gen Pract 2005; 55(515):444.
   PubMed Web of Science ®Google Scholar
• Keen J, Oliver P, Rowse G, Mathers N. Does methadone maintenance treatment based on the new national guidelines work in a primary care setting? Br J Gen Pract 2003; 53(491):461–467.
   PubMed Web of Science ®Google Scholar
• Hutchinson SJ, Taylor A, Gruer L, Barr C, Mills C, Elliott L. One-year follow-up of opiate injectors treated with oral methadone in a GP-centred programme. Addiction 2000; 95(7):1055–1068.
   PubMed Web of Science ®Google Scholar
• Gossop M. Treating Drug Misuse Problems: Evidence of Effectiveness. London, UK: Department of Health, National Treatment Agency, 2006.
   Google Scholar
• Mulholland D. A study to validate the exit information recorded on the Central Treatment List between 1999 and 2003 [MFPHMI thesis], 2007.
   Google Scholar
• Mullen L, Long J, Barry J, Keenan E, Mulholland D, Grogan L, Delargy I. Factors predicting completion in a group of opiate users entering a detoxification programme. Ir J Med Sci 2010; 179(4):569–573.
   PubMed Web of Science ®Google Scholar
• Deck D, Carlson M. Retention in publicly funded methadone maintenance treatment in two western states. J Behav Health Serv Res 2005; 32(1):43–60.
   PubMed Web of Science ®Google Scholar
• Gunderson EW, Fiellin DA. Office-based maintenance treatment of opioid dependence: How does it compare with traditional approaches? CNS Drugs 2008; 22(2):99.
   PubMed Web of Science ®Google Scholar